Search results for: 'paint part analyst for laboratory develop test life'

30 Mar 2023  |  North America  |  Customer Research

Global Laboratory Product Purchasing Trends, 2022–2023

End–user Perspectives on Laboratory Spending Reveals Modest 2023 Budget Increases Following robust 2022 Spending

Infographics

×

Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey from October to November 2022 examining their laboratories’ product purchasing process in 2022 and expectations for 2023. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The study presents year-over-...

13 Jul 2016  |  North America  |  Market Research

Strategic Analysis of the European and North American Paint Additives Market

Transition to Water-Borne Coatings Drives Changes in Product Mix

Infographics

×

This research service identifies the major industry drivers, restraints, regulatory trends and technology trends affecting the European and North American Paint Additives Market. The product segments covered in this research are rheology modifiers, defoamers, surfactants, adhesion promoters, surface additives, wax additives, light stabilizers, bioc...

19 Sep 2023  |  North America  |  Market Research

Growth Opportunities for Clinical Laboratory Services in Asia-Pacific

Proliferation of High-end Specialized Testing and Interconnected Lab Networks Fuel Growth Potential

Infographics

×

Clinical labs are the foundation of the healthcare ecosystem. This research overviews the Asia-Pacific (APAC) clinical laboratory services industry for the period 2022–2028. Country-specific and vertical-specific forecasts are provided from 2023 to 2028 using a base year of 2022. Frost & Sullivan focused on APAC following various events unfolding f...

Frost & Sullivan s global IoT industry predictions for calendar 2024 are the result of aggregated input from Frost & Sullivan regional IoT and Edge research teams. Research analysts input leverages the extensive Frost & Sullivan knowledge base, as well as primary and secondary research. This Top 10 Growth Opportunities report reflects the hot ...

An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...

The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results. By stre...

The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...

Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2020 that centered on the state of their laboratories in 2020 and their expectations for 2021. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year-ove...

The main objective of this research is to estimate test volumes and unit prices for a wide variety of LDTs (genetic) and a few high volume FDA tests for selective therapeutic areas. The tests are categorized by their intended uses across the diagnostic spectrum (risk assessment, screening, diagnosis, staging and prognosis, therapy selection, therap...